Mark S. McNulty
Profile
Mark S.
McNulty is Chief Executive and Financial Officer and Secretary of Xylos Corp.
He joined Xylos in 2000 as Chief Financial Officer.
Prior to joining Xylos, he was Director of Finance, Information Technology and Human Resources for Exogen, Inc. Previously, he was Corporate Controller of Osteotech, Inc. Mr. McNulty began his career at Johnson & Johnson, Inc.
Former positions of Mark S. McNulty
| Companies | Position | End |
|---|---|---|
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Exogen, Inc.
 Exogen, Inc. Medical SpecialtiesHealth Technology Exogen, Inc. designs, develops, manufactures and markets medical devices for treatment of musculoskeletal injury and disease. The company's products include sonic acclerated fracture healing system and mechanical stress devices. The products are sold in the United States, Europe and Japan. | Director of Finance/CFO | - |
Osteotech, Inc.
 Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Comptroller/Controller/Auditor | - |
Xylos Corp.
 Xylos Corp. BiotechnologyHealth Technology Xylos Corp. provides biotechnology solutions. The firm operates as a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. The company was founded by Gonzalo C. Serafica in 1996 and is headquartered in Newtown, PA. | Chief Executive Officer | - |
Training of Mark S. McNulty
| Rutgers State University of New Jersey | Masters Business Admin |
| Bucknell University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| Private companies | 3 |
|---|---|
Xylos Corp.
Xylos Corp. BiotechnologyHealth Technology Xylos Corp. provides biotechnology solutions. The firm operates as a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. The company was founded by Gonzalo C. Serafica in 1996 and is headquartered in Newtown, PA. | Health Technology |
Exogen, Inc.
Exogen, Inc. Medical SpecialtiesHealth Technology Exogen, Inc. designs, develops, manufactures and markets medical devices for treatment of musculoskeletal injury and disease. The company's products include sonic acclerated fracture healing system and mechanical stress devices. The products are sold in the United States, Europe and Japan. | Health Technology |
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Health Technology |
- Stock Market
- Insiders
- Mark S. McNulty
